OUR TEAM

AtlasMedx leadership team combines many years of comprehensive pharmaceutical, operational and commercialization experience. Our management team has:

  • Extensive expertise in biopharmaceutical Industry, drug development, molecular and cell biology, cancer biology, clinical pharmacology, biochemistry, immunology, medicinal chemistry, clinical oncology, surgery, clinical trials design and management, patient care…

  • Experience building and managing businesses, attracting top talent, and closing licensing/partnership deals

LEADERSHIP

AtlasMedx is advised by an outstanding group of industry leaders with significant expertise in drug development, targeted cancer therapeutics, clinical development, and commercialization, combined with extensive management and leadership experience in corporate development and management. 

HASSAN L ALAOUI PH.D

President, CEO, and Founder

PAMELA N MUNSTER M.D

Chief Medical Advisor

DAVID JABLONS M.D

Chief Scientific Officer and Founder

DANIEL HUNT J.D

Chief Business Officer

CSABA J PETO PH.D

VP, Medicinal Chemistry and Founder

BONNIE WETTERSTEN

VP, Clinical Operations

ROBIN ASH

VP, Project Management

PAM MONTGOMERY PH.D

VP, Quality Assurance & Quality Control

KHAWLA ABU-IZZA PH.D

VP, Chemistry, Manufacturing & Controls

CINDY ZEE

VP, Regulatory Affairs

MICHAEL MANN M.D

BD Clinical Advisor (BDA)

CORPORATE & SCIENTIFIC ADVISORS